February 5, 2025 Abbott India posts higher Q3 profit on strong demand Drugmaker Abbott India reported a jump in third-quarter profit on Wednesday, helped by strong demand for its gastrointestinal ...

The shares of the American pharma giant Abbott's Indian arm, Abbott India surged in the intraday trade on Thursday, February 6. This was no exception, as the company carried on from where it had left.

Through the CKCK initiative, Abbott and India’s neurology community are making strides in transforming vertigo care, ensuring that no case goes unchecked.

ICICI Securities is bullish on Abbott India has recommended buy rating on the stock with a target price of Rs 32700 in its research report dated February 06, 2025. Any tariffs on India or ...